Author

Joachim Labenz 1

1 Diakonie Klinikum Jung-Stilling Hospital,Siegen,Germany

ALGINATE AS ADD-ON FOR GORD WITH INSUFFICIENT PPI EFFECT: THE LOPA III TRIAL

Joachim Labenz

ALGINATE AS ADD-ON FOR GORD WITH INSUFFICIENT PPI EFFECT: THE LOPA III TRIAL

Matthias Müller, Gisela Labenz, Daniela Borkenstein, Joachim Labenz

GERD PATIENTS ACROSS CULTURES HAVE SIMILAR CONCERNS: A COMPARISON OF LOST“ GERD PATIENTS IN GERMANY AND BRAZIL

Caroline Saad, Joachim Labenz

GLOBAL CLINICAL EXPERIENCE WITH ENDOSTIM® LOWER ESOPHAGEAL SPHINCTER STIMULATION THERAPY: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE OPEN LABEL CLINICAL TRIALS

Grigorios I Leontiadis, Leonardo Rodríguez, Peter D. Siersema, Joachim Labenz

GORD PATIENTS ARE FREQUENTLY DISSATISFIED ON LONG-TERM PPI: EXPLORING THE REASON(S) AND MANAGEMENT IN ROUTINE CLINICAL CARE (LOPA II STUDY)

Joachim Labenz

GORD PATIENTS ARE FREQUENTLY DISSATISFIED ON LONG-TERM PPI: EXPLORING THE REASON(S) AND MANAGEMENT IN ROUTINE CLINICAL CARE (LOPA II STUDY)

Joachim Labenz, Gisela Labenz, Matthias Müller, Dietmar Stephan, Frank Willeke

HIGH PREVALENCE OF GERD IN PATIENS SYMPTOMATIC ON PPI: RESULTS OF THE BRAZILIAN LOST PATIENT (LOPA) STUDY

Caroline Saad, Joachim Labenz, Stephen E. Attwood

INADEQUATE SYMPTOM CONTROL ON LONG-TERM PPI THERAPY IN GERD - FACT OR FICTION?

Joachim Labenz

INADEQUATE SYMPTOM CONTROL ON LONG-TERM PPI THERAPY IN GERD – FACT OR FICTION?

Joachim Labenz, Gisela Labenz, Dietmar Stephan, Frank Willeke

INADEQUATE SYMPTOM CONTROL ON LONG-TERM PPI THERAPY IN GERD ? FACT OR FICTION? (LOPA II STUDY)

Joachim Labenz, Gisela Labenz, Dietmar Stephan, Frank Willeke

Item 1 - 10 / 24
1
2 3